1.. Introduction   {#sec1}
==================

The type VI secretion system (T6SS) is composed of 14 core components, TssA--TssM and PAAR, which together form a contractile machine that injects protein effectors into target cells (Pukatzki *et al.*, 2007[@bb19]; Shalom *et al.*, 2007[@bb23]; Zheng & Leung, 2007[@bb33]; Boyer *et al.*, 2009[@bb4]; Leiman *et al.*, 2009[@bb16]; Cianfanelli *et al.*, 2016[@bb7]). The core components form a number of sub­complexes, including the sheath/tube complex, membrane complex and baseplate (Leiman *et al.*, 2009[@bb16]; Basler *et al.*, 2012[@bb2]; Shneider *et al.*, 2013[@bb25]; Brunet *et al.*, 2015[@bb6]; Durand *et al.*, 2015[@bb9]). TssB and TssC form the contractile sheath, which surrounds the TssD inner tube (Bönemann *et al.*, 2009[@bb3]; Leiman *et al.*, 2009[@bb16]; Basler *et al.*, 2012[@bb2]; Brunet *et al.*, 2014[@bb5]). TssI and PAAR sit on top of the tube and may be decorated with covalently or noncovalently attached effector proteins (Pukatzki *et al.*, 2007[@bb19]; Leiman *et al.*, 2009[@bb16]; Shneider *et al.*, 2013[@bb25]). Upon contraction of the sheath against the baseplate, the tube, which can also carry effector proteins, passes through the baseplate and is ejected from the cell (Pukatzki *et al.*, 2006[@bb20]; Basler *et al.*, 2012[@bb2]; Silverman *et al.*, 2013[@bb26]). TssH then acts to recycle the sheath components post-contraction for reassembly in the extended state (Bönemann *et al.*, 2009[@bb3]; Basler *et al.*, 2012[@bb2]; Kapitein *et al.*, 2013[@bb15]). TssJ, TssL and TssM form a complex that anchors the contractile machinery to the cell envelope through interactions with the baseplate (Aschtgen *et al.*, 2010[@bb1]; Zoued *et al.*, 2013[@bb34]; Brunet *et al.*, 2015[@bb6]; Durand *et al.*, 2015[@bb9]). TssE, TssF, TssG and TssK are components of the baseplate, which serves as a platform for priming of the sheath and tube assembly (Basler *et al.*, 2012[@bb2]; English *et al.*, 2014[@bb11]; Brunet *et al.*, 2015[@bb6]).

Following phylogenetic analysis, TssA proteins have been classified into three clades (TssA1--TssA3; Planamente *et al.*, 2016[@bb18]), with representative TssAs belonging to clades TssA1 (PA0082 from *Pseudomonas aeruginosa*; P.a TssA1) and TssA2 (Ec042_4540 from enteroaggregative *Escherichia coli*; E.c TssA2) having previously been the subject of biochemical and structural studies (Planamente *et al.*, 2016[@bb18]; Zoued *et al.*, 2016[@bb35]). The P.a and E.c TssAs have been shown to interact with the T6SS sheath, inner tube and components of the baseplate, with E.c TssA2 also interacting with the membrane complex (Planamente *et al.*, 2016[@bb18]; Zoued *et al.*, 2016[@bb35]). P.a TssA1 is proposed to contain two domains which form a ring structure comprising the C-terminal domain with a flexible peripheral N-terminal domain (Planamente *et al.*, 2016[@bb18]). Similarly, in E.c TssA2 the C-terminal domain oligomerizes to produce a dodecameric structure of two stacked rings with *D* ~6~ symmetry (Zoued *et al.*, 2016[@bb35]). In E.c TssA2 the N-terminal region is predicted to form arms which extend out from the C-terminal dodecamer core (Zoued *et al.*, 2016[@bb35]). The structure of part of the E.c TssA2 N-terminal region, Nt2, forms a dimer (Zoued *et al.*, 2016[@bb35]). Bioinformatic analysis identified a conserved region within both the P.a TssA1 and E.c TssA2 N-terminal domains, referred to as ImpA_N (Planamente *et al.*, 2016[@bb18]; Zoued *et al.*, 2017[@bb36]). P.a TssA1 was observed to localize at one end of the sheath, whilst E.c TssA2 was seen to move away from an initial site at the membrane concomitant with sheath polymerization (Planamente *et al.*, 2016[@bb18]; Zoued *et al.*, 2016[@bb35]). Based on these observations of P.a TssA1 and some low-level predicted similarities in secondary structure, it was suggested that the TssA1 C-terminal region corresponds to the C-terminal region of the phage T4 baseplate component gp6, thereby identifying P.a TssA1 as a possible baseplate component (Planamente *et al.*, 2016[@bb18]). On the other hand, E.c TssA2 was predicted to be involved in recruitment of the baseplate assembly to the membrane complex and subsequent polymerization of the TssD tube and TssB/TssC sheath (Zoued *et al.*, 2016[@bb35]).

*Burkholderia cenocepacia* TssA (B.c TssA), locus tag I35_RS01755, is a member of TssA3, the TssA clade that has yet to be investigated (Planamente *et al.*, 2016[@bb18]). In this paper, we describe the production of constructs of B.c TssA representing the predicted N-terminal and C-terminal domains. Overexpression of the domains, their purification and their crystallization resulted in the production of diffraction-quality crystals, analysis of which provides preliminary information on their stoichiometry, symmetry and structural organization.

2.. Materials and methods   {#sec2}
===========================

2.1.. Macromolecule production   {#sec2.1}
--------------------------------

Coding sequences for the predicted N-terminal domain (Nt1) and C-terminal domain (CTD) of B.c TssA (UniProt A0A1V2WLD6) were amplified from *B. cenocepacia* strain H111 (Römling *et al.*, 1994[@bb21]) by PCR using the appropriate combinations of primers as shown in Table 1[▸](#table1){ref-type="table"}. The DNA products were ligated to either plasmid pET-14b (Novagen; encoding a His~6~ purification tag and a thrombin cleavage site) or pMAL-c5X \[NEB; encoding a maltose-binding protein (MBP) solubility tag and a Factor Xa cleavage site\], followed by transformation of *E. coli* strain JM83 (Yanisch-Perron *et al.*, 1985[@bb31]). Construct details are shown in Table 1[▸](#table1){ref-type="table"}.

A B.c His~6~-TssA Nt1 construct was overexpressed in *E. coli* BL21 (DE3) cells (Studier & Moffatt, 1986[@bb27]) grown in brain heart infusion broth (Becton Dickinson) at 37°C to an OD~600~ of 0.5--0.7, whereupon expression was induced by the addition of 1 m*M* IPTG followed by incubation for a further 2--3 h. B.c His~6~-TssA Nt1 was purified from clarified cell lysate in 50 m*M* Tris pH 8.0, 500 m*M* NaCl, applied onto a HisTrap HP column (GE Healthcare Life Sciences) and eluted with a linear gradient of imidazole (0--350 m*M*) in 50 m*M* Tris pH 8.0, 500 m*M* NaCl. Fractions containing the B.c His~6~-TssA Nt1 protein were concentrated using a 30 kDa molecular-weight cutoff concentrator and washed with 10 m*M* Tris pH 8.0 for crystallization.

The B.c MBP-TssA CTD fusion protein was overproduced in *E. coli* ER2523 cells (NEB Express) grown in Lennox broth containing 0.2% glucose (Lennox, 1955[@bb40]) at 37°C to an OD~600~ of 0.6--0.7, whereupon protein overexpression was induced with 0.3 m*M* IPTG and incubation of the culture continued at the same temperature for a further 2--3 h. To prepare selenomethionine-incorporated B.c MBP-TssA CTD protein (B.c SeMet-MBP-TssA CTD), 2 × 500 ml of cells were grown as described above and harvested prior to induction. The cell pellets were then resuspended in selenomethionine minimal medium, harvested and the resuspension was added to 2 × 500 ml selenomethionine minimal medium \[10.5 g l^−1^ K~2~HPO~4~, 1.0 g l^−1^ (NH~4~)~2~SO~4~, 4.5 g l^−1^ KH~2~PO~4~, 0.5 g l^−1^ trisodium citrate·2H~2~O, 5.0 g l^−1^ glycerol and 0.5 g l^−1^ each of adenine, guanosine, thymine and uracil\] supplemented with 1.0 g l^−1^ MgSO~4~·7H~2~O, 4.0 mg l^−1^ thiamine, 100 mg l^−1^ each of [l]{.smallcaps}-lysine, [l]{.smallcaps}-phenylalanine and [l]{.smallcaps}-threonine, 50 mg l^−1^ each of [l]{.smallcaps}-isoleucine, [l]{.smallcaps}-leucine and [l]{.smallcaps}-valine, 40 mg l^−1^ seleno-[l]{.smallcaps}-methionine and 2.0 g l^−1^ glucose. Growth was continued for 1 h at 37°C prior to the induction of B.c MBP-TssA CTD expression by the addition of 0.3 m*M* IPTG and subsequent growth at 37°C overnight.

Harvested B.c MBP-TssA CTD- and B.c SeMet-MBP-TssA CTD-overexpressing cells were each resuspended in column-binding buffer (50 m*M* Tris--HCl pH 8.0, 200 m*M* NaCl) and the cells were lysed by sonication. The cell lysate was cleared by centrifugation before being applied onto amylose resin (NEB) equilibrated with column-binding buffer. After washing the resin with column-binding buffer, the bound material was then eluted in the same buffer with the addition of 10 m*M* maltose. Fractions containing the fusion protein were concentrated and then digested with Factor Xa (5 µg per milligram of protein; NEB) in the presence of 2 m*M* CaCl~2~ at room temperature for ∼14 h to release the target protein from MBP. Following cleavage of the MBP, the products were separated by gel filtration on a Superdex 200 column (GE Healthcare Life Sciences) in 50 m*M* Tris--HCl pH 8.0, 500 m*M* NaCl. The B.c TssA CTD protein obtained from gel filtration was applied to a final amylose column to remove any uncleaved B.c MBP-TssA CTD fusion molecules. This step was added to avoid heterogeneity of the sample. The protein was then concentrated and buffer-exchanged into 5 m*M* Tris--HCl pH 8.0, 50 m*M* NaCl for crystallization. The purified B.c TssA CTD protein has an additional four non-native residues (ISHM) at the N-terminus following proteolytic release from the N-terminal MBP solubility tag (Table 1[▸](#table1){ref-type="table"}).

2.2.. Crystallization   {#sec2.2}
-----------------------

B.c TssA protein constructs were set down into sitting-drop crystallization trials using a Matrix Hydra II Plus One robot, with 200 nl:200 nl drops and a 50 µl reservoir, or hanging-drop crystallization trials, and stored at 17°C. A selection of crystallization condition suites were used for screening, including JCSG+, ProPlex, PACT, Classics, MPD, AmSO~4~, PEGs and pHClear (Qiagen, Molecular Dimensions). B.c His~6~-TssA Nt1 crystals grew in sitting-drop trial conditions consisting of 0.16 *M* calcium acetate, 0.08 *M* sodium cacodylate buffer pH 6.5, 14.4%(*w*/*v*) PEG 8000, 20%(*v*/*v*) glycerol. B.c TssA CTD produced crystals in sitting-drop trial conditions consisting of 0.1 *M* sodium chloride, 0.1 *M* Tris pH 8.0, 15%(*v*/*v*) ethanol, 5%(*v*/*v*) MPD. B.c SeMet-TssA CTD produced crystals in hanging-drop trial conditions consisting of 1 *M* ammonium sulfate, 2%(*w*/*v*) PEG 3350, 0.1 *M* bis-tris pH 6.0. Crystallization information is shown in Table 2[▸](#table2){ref-type="table"}.

2.3.. Data collection, processing and analysis   {#sec2.3}
------------------------------------------------

Data were collected from B.c His~6~-TssA Nt1 crystals \[cryoprotected in 0.16 *M* calcium acetate, 0.08 *M* sodium cacodylate buffer pH 6.5, 16.4%(*w*/*v*) PEG 8000, 30%(*v*/*v*) glycerol\] on beamline I04-1 at Diamond Light Source. The data were processed to 1.87 Å resolution using the `-3daii` option in *xia*2 (Collaborative Computational Project, Number 4, 1994[@bb8]; Evans, 2006[@bb12]; Kabsch, 2010[@bb13]; Winter, 2010[@bb29]) and indicated that the crystals belonged to space group *P*2~1~2~1~2 (unit-cell parameters *a* = 49.7, *b* = 125.4, *c* = 45.5 Å). Data-collection and processing statistics are shown in Table 3[▸](#table3){ref-type="table"}.

Data were collected from B.c TssA CTD crystals \[cryoprotected in 0.1 *M* sodium chloride, 0.1 *M* Tris pH 8.0, 15%(*v*/*v*) ethanol, 25%(*v*/*v*) glycerol\] on beamline I04 at Diamond Light Source. Data were processed to 3.79 Å resolution using the `-3daii` option in *xia*2 (Collaborative Computational Project, Number 4, 1994[@bb8]; Sauter *et al.*, 2004[@bb22]; Evans, 2006[@bb12]; Zhang *et al.*, 2006[@bb32]; Kabsch, 2010[@bb13]; Winter, 2010[@bb29]) and indicated that the crystals belonged to space group *I*222. Data-collection and processing statistics are shown in Table 3[▸](#table3){ref-type="table"}. A self-rotation function was calculated on all of the data from crystals of B.c TssA CTD using an integration radius of 44 Å in *POLARRFN* (Winn *et al.*, 2011[@bb28]). Self Patterson functions on the native data were calculated using *FFT for Patterson* (Winn *et al.*, 2011[@bb28]).

B.c His~6~-TssA Nt1 crystals were subjected to the sub­limination of elemental iodine for ∼3 h prior to cryoprotection in 0.16 *M* calcium acetate, 0.08 *M* sodium cacodylate buffer pH 6.5, 16.4%(*w*/*v*) PEG 8000, 30%(*v*/*v*) glycerol and data collection on beamline I03 at Diamond Light Source. The data were processed to 2.01 Å resolution with *fast_dp* (Winter & McAuley, 2011[@bb30]) and indicated that the crystals belonged to space group *P*2~1~2~1~2 (unit-cell parameters *a* = 45.6, *b* = 49.8, *c* = 126.1 Å). Data-collection statistics are shown in Table 3[▸](#table3){ref-type="table"}.

Data were collected from B.c SeMet-TssA CTD crystals \[cryoprotected in 1--1.2 *M* ammonium sulfate, 3--4%(*w*/*v*) PEG 3350, 0.1 *M* bis-tris pH 6.0, 30%(*v*/*v*) glycerol\] on beamline I03 at Diamond Light Source. The data were processed to 2.86 Å resolution using the `-3d` option in *xia*2 (Collaborative Computational Project, Number 4, 1994[@bb8]; Evans, 2006[@bb12]; Kabsch, 2010[@bb13]; Winter, 2010[@bb29]) and indicated that the crystals belonged to space group *I*222 (unit-cell parameters *a* = 46.3, *b* = 201.3, *c* = 263.9 Å). Data-collection statistics are shown in Table 3[▸](#table3){ref-type="table"}.

3.. Results and discussion   {#sec3}
============================

3.1.. Construct design   {#sec3.1}
------------------------

The design of the constructs for the N- and C-terminal domains of B.c TssA was based on an analysis of the pattern of sequence conservation across the different clades of TssA and resulted in stable, soluble samples of the proteins encoded by these regions of the gene. Constructs of the predicted N-terminal domain (Nt1) and C-terminal domain (CTD) of B.c TssA produced crystals (Fig. 1[▸](#fig1){ref-type="fig"}) which diffracted to high resolution.

3.2.. TssA data analysis   {#sec3.2}
--------------------------

Analysis of the Matthews coefficient of the B.c His~6~-TssA Nt1 crystals suggests that the crystals contain one molecule of ∼30.7 kDa in the asymmetric unit, with a *V* ~M~ of 2.31 Å^3^ Da^−1^ (Matthews, 1968[@bb17]; Kantardjieff & Rupp, 2003[@bb14]; Winn *et al.*, 2011[@bb28]). In contrast, the contents of the asymmetric unit of the B.c TssA CTD crystals could not be confidently assigned from analysis of the Matthews coefficient. Consideration of possible values of *V* ~M~ suggests that the asymmetric unit contains between nine and 21 subunits (4.13--1.77 Å^3^ Da^−1^; Matthews, 1968[@bb17]; Kantardjieff & Rupp, 2003[@bb14]; Winn *et al.*, 2011[@bb28]). It has previously been reported that the TssA CTD acts as an oligomerization domain which produces ring-like or star-like structures, as has been shown for P.a TssA1 and E.c TssA2, respectively (Planamente *et al.*, 2016[@bb18]; Zoued *et al.*, 2016[@bb35]). Self Pattersons calculated using the native data to 6 or 3.79 Å resolution showed no significant peaks above 15% of the origin, consistent with the absence of translational symmetry in the crystal. A self-rotation function was calculated on the B.c TssA CTD data using an integration radius of 44 Å to detect the presence of noncrystallographic symmetry. This identified peaks on the κ = 180° section with a height of approximately 70% of the origin corresponding to twofold axes located in the *bc* plane every 11.25° (Fig. 2[▸](#fig2){ref-type="fig"}). Consideration of the rotational symmetry and apparent molecular weight, determined by gel-filtration analysis (Fig. 2[▸](#fig2){ref-type="fig"}), suggests that the quaternary structure of B.c TssA CTD is composed of 32 subunits in *D* ~16~ symmetry. This suggests that the asymmetric unit contains eight subunits with an unusually high *V* ~M~ (4.64 Å^3^ Da^−1^; Matthews, 1968[@bb17]; Kantardjieff & Rupp, 2003[@bb14]; Winn *et al.*, 2011[@bb28]). A preliminary electron-density map was calculated using SAD data to 2.86 Å resolution from the selenomethionine derivative of the B.c TssA CTD crystals, with an initial chain trace confirming the presence of B.c TssA CTD in the crystals and the nature of the symmetry indicated by the self-rotation function (Fig. 2[▸](#fig2){ref-type="fig"}). Similarly, a preliminary electron-density map has been calculated using SAD data to 2.01 Å resolution from iodine-exposed B.c His~6~-TssA Nt1 crystals (Fig. 3[▸](#fig3){ref-type="fig"}). Refinement of the structures and attempts to extend the resolution of the data are ongoing.
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![(*a*) SDS--PAGE analysis of protein purification of the B.c His~6~-TssA Nt1 construct. Lane *M*, Mark12 marker (labelled in kDa). Lane 1, cell debris. Lane 2, cell-free extract. Lane 3, flowthrough (Ni column). Lane 4, final preparation. (*b*) SDS--PAGE analysis of protein purification of the B.c SeMet MBP-TssA CTD construct. The protein, indicated by the arrow, is shown to be ∼90% pure in the final preparation samples and thus was used for crystallization. Lane *M*, Mark12 marker (labelled in kDa). Lane 1, cell-free extract. Lane 2, unbound material (amylose column). Lane 3, B.c SeMet MBP-TssA CTD. Lane 4, after MBP cleavage. Lane 5, after gel filtration. Lane 6, final preparation. (*c*) B.c His~6~-TssA Nt1 crystals grown in 0.16 *M* calcium acetate, 0.08 *M* sodium cacodylate buffer pH 6.5, 14.4%(*w*/*v*) PEG 8000, 20%(*v*/*v*) glycerol. (*d*) B.c TssA CTD crystals grown in 0.1 *M* sodium chloride, 0.1 *M* Tris pH 8.0, 15%(*v*/*v*) ethanol, 5%(*v*/*v*) MPD.](f-74-00536-fig1){#fig1}

![(*a*) The self-rotation function for B.c TssA CTD crystals calculated on all data from 55.90 to 3.79 Å resolution using a 44 Å radius of integration. The section shown corresponds to κ = 180°, with the orthogonal *x*, *y* and *z* axes along the crystallographic *a*, *b* and *c* axes, respectively. Noncrystallographic twofold axes can be seen every 11.25° in the *bc* plane at approximately 70% of the origin. The image was generated in *POLARRFN* (Winn *et al.*, 2011[@bb28]). (*b*) Gel-filtration chromatogram of B.c SeMet-MBP-TssA CTD protein, with UV absorption (280 nm) shown as a dotted blue line and the elution volume (70.77 ml) corresponding to B.c TssA CTD shown above the curve. Inset: calibration curve for the gel-filtration column, with *K* ~av~ = 0.4 (*V* ~e~ = 70.77 ml) highlighted corresponding to a molecular mass of ∼3.55 × 10^5^ Da for B.c TssA CTD.](f-74-00536-fig2){#fig2}

![Preliminary electron-density maps, contoured at ∼1.0σ, representing (*a*) a helical section of B.c TssA CTD. The large side chain visible towards the C-­terminal end of the helix corresponds to Trp339, and density can also be seen for the nearby Trp347. Phases were obtained from *SHELX* (Sheldrick, 2008[@bb24]). (*b*) A helical section of the B.c His~6~-TssA Nt1 domain. The large side chain visible at the C-terminal end of the helix corresponds to Phe247, and density can also be seen for the side chain of the adjacent Arg246. Phases were obtained from *fast_ep* and *SHELX* (Sheldrick, 2008[@bb24]). Images were generated in *Coot* (Emsley *et al.*, 2010[@bb10]).](f-74-00536-fig3){#fig3}

###### Construct information

  Construct                                       His~6~-TssA Nt1                                                                                                                                                                                                                                                                              MBP-TssA CTD
  ----------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------
  B.c TssA amino acids                            1--255                                                                                                                                                                                                                                                                                       303--373
  Tag details                                     MGSSHHHHHHSSGLVPRGSH                                                                                                                                                                                                                                                                         (MBP)NSSSNNNNNNNNNNLGIEGR/ISHM[†](#tfn1){ref-type="table-fn"}
  Construct sequence                              [MGSSHHHHHHSSGLVPRGSH]{.ul}MPINLPELLTPISEASPSGDDLLFSNEFDAIQDARRYDDPTLDQGEWVTEIKEADWGFVVDHAGELLRTRTKDLRLAVWLTEALALEDGITGLTEGYALLEGLCREFWDTFHPLPEDDDIEHRLGNVAWLSGRTAELLRAVPLTDGASNAFSTLDWEVAQHVAQSIKRDPEHADDIARGKPSIEQIDASRRVTSIAFYTALLANLKAFEFALDAFEERLVERAGDSAPSFRQARDAFETVYRLAERFAREQGYTG   [(MBP)NSSSNNNNNNNNNNLGIEGR/ISHM]{.ul}IQNRAQAVDQLRAVARYFRQTEPHSPVAYLADKAAEWADMPLHKWLESVVKDDGSLSHIRELLGVRPDEQS
  Forward primer[‡](#tfn2){ref-type="table-fn"}   pET-14b-iotAfor, GCGC**CAT[ATG]{.ul}**CCGATCAATCTCCCCGA                                                                                                                                                                                                                                      pET-14b-ACTDfor3, GCGC**CAT[ATG]{.ul}**ATCCAGAACCGTGCGCAGGC
  Reverse primer[‡](#tfn2){ref-type="table-fn"}   pET-14b-TssA-NTDrev, GCGC**GGATCC** [TTA]{.ul}GCCGGTATAGCCCTGTTCGC                                                                                                                                                                                                                           pET-14b-iotArev, GCGC**GGATCC**TGCGT[TTA]{.ul}CGACTGCTCGTC
  Restriction enzymes                             NdeI and BamHI                                                                                                                                                                                                                                                                               NdeI and BamHI
  Expression vector                               pET-14b                                                                                                                                                                                                                                                                                      pMAL-c5X
  Antibiotic                                      100 µg ml^−1^ ampicillin                                                                                                                                                                                                                                                                     100 µg ml^−1^ ampicillin
  Expression host                                 *E. coli* BL21 (DE3)                                                                                                                                                                                                                                                                         *E. coli* ER2523 (NEB Express)

MBP is maltose-binding protein; IEGR is the Factor Xa recognition site; / indicates the Factor X cleavage site. Tags are highlighted as underlined regions of the construct sequences.

Bold sequences indicate restriction sites. Translation initiation and termination codons are underlined.

###### Crystallization

  Construct                           His~6~-TssA Nt1                                                                                                      TssA CTD                                                                              SeMet-TssA CTD
  ----------------------------------- -------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- -----------------------------------------------------------------------
  Method                              Sitting-drop vapour diffusion                                                                                        Sitting-drop vapour diffusion                                                         Hanging-drop vapour diffusion
  Composition of reservoir solution   0.16 *M* calcium acetate, 0.08 *M* sodium cacodylate buffer pH 6.5, 14.4%(*w*/*v*) PEG 8000, 20%(*v*/*v*) glycerol   0.1 *M* sodium chloride, 0.1 *M* Tris pH 8.0, 15%(*v*/*v*) ethanol, 5%(*v*/*v*) MPD   1 *M* ammonium sulfate, 2%(*w*/*v*) PEG 3350, 0.1 *M* bis-tris pH 6.0
  Volume and ratio of drop            200 nl:200 nl                                                                                                        200 nl:200 nl                                                                         2 µl:1 µl (protein:reservoir)
  Volume of reservoir (µl)            50                                                                                                                   50                                                                                    1000

###### Data-collection and processing statistics

Values in parentheses are for the highest resolution shell.

  Construct                      His~6~-TssA Nt1            His~6~-TssA Nt1 + iodine   TssA CTD                   SeMet-TssA CTD
  ------------------------------ -------------------------- -------------------------- -------------------------- --------------------------
  Wavelength (Å)                 0.92000                    1.70000                    0.97949                    0.97922
  Beamline                       I04-1                      I03                        I04                        I03
  Detector                       PILATUS 2M                 PILATUS 6M                 PILATUS 6M-F               PILATUS3 6M
  Rotation range per image (°)   0.2                        0.2                        0.2                        0.1
  Total rotation range (°)       90                         720                        180                        360
  Exposure time per image (s)    0.2                        0.2                        0.2                        0.05
  Data-processing package        *xia*2 `-3daii`            *fast_dp*                  *xia*2 `-3daii`            *xia*2 `-3d`
  Space group                    *P*2~1~2~1~2               *P*2~1~2~1~2               *I*222                     *I*222
  *a*, *b*, *c* (Å)              49.7, 125.4, 45.5          45.6, 49.8, 126.1          46.9, 203.0, 267.9         46.3, 201.3, 263.9
  α, β, γ (°)                    90.0, 90.0, 90.0           90.0, 90.0, 90.0           90.0, 90.0, 90.0           90.0, 90.0, 90.0
  Resolution range (Å)           62.69--1.87 (1.92--1.87)   29.68--2.01 (2.06--2.01)   55.90--3.79 (3.89--3.79)   80.61--2.86 (2.93--2.86)
  *R* ~merge~                    0.067 (0.495)              0.131 (0.761)              0.221 (0.871)              0.207 (2.520)
  *R* ~p.i.m.~                   0.051 (0.372)              0.031 (0.174)              0.112 (0.487)              0.064 (0.747)
  〈*I*/σ(*I*)〉                 10.8 (2.0)                 20.6 (3.4)                 7.6 (2.0)                  11.1 (1.1)
  Completeness (%)               98.4 (99.3)                98.4 (79.0)                99.4 (99.7)                100.0 (100.0)
  Multiplicity                   3.3 (3.3)                  23.0 (18.7)                5.7 (5.3)                  13.0 (13.2)
  Total reflections              77962                      448717                     75744                      382400
  Unique reflections             23839                      19523                      13207                      29304

[^1]: These authors contributed equally.
